Metagenomics is a key tool used in modern biotechnology
which helps in isolating and identifying microbes directly from their
environments without the need to culture them in a laboratory. It allows the
study of uncultured microbial communities that play important roles in various
industrial domains such as bioremediation, biofuel production and disease
diagnosis.
The
metagenomics market is estimated to be valued at USD 2.18 Bn in 2024 and is
expected to reach USD 3.77 Bn by 2031, exhibiting a compound annual growth rate
(CAGR) of 8.1% from 2024 to 2031.
Key Takeaways
Key players operating in the Metagenomics are Bio-Rad Laboratories, Inc.,
Illumina, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene
Co., Ltd., Promega Corporation, QIAGEN, Takara Bio, Inc., Oxford Nanopore
Technologies, F. Hoffmann-La Roche Ltd, and PacBio. The growing application of
metagenomic techniques in drug discovery and development is expected to drive
the demand. Technological advancements including improvements in
next-generation sequencing platforms and bioinformatics tools for data analysis
have enhanced metagenomic studies.
Market Trends
Growing adoption of shotgun Metagenomics
Market Size sequencing: It allows the profiling of whole microbial
community structure without requiring prior knowledge of constituent species.
It is increasingly being used for various applications including soil and water
microbiome analysis.
Increasing focus on human microbiome analysis: Metagenomic techniques play a
vital role in characterizing human microbiomes in various bodily sites and
linking them to health and disease conditions like obesity, diabetes,
gastrointestinal disorders. This is expected to further widen the scope of
metagenomics.
Market Opportunities
Wide scope in disease diagnosis: Metagenomic pathogen identification methods have
the potential to revolutionize infectious disease diagnostics by rapidly
detecting pathogens directly from clinical samples without the need for
bacterial culturing.
Applications in bioremediation and wastewater treatment: Metagenomics can help
explore the diverse microbial communities involved in biodegradation of
environmental pollutants and wastewater treatment, paving way for developing
insights on optimizing such processes.
Impact of COVID-19 on Metagenomics Market Growth
The COVID-19 pandemic has impacted the growth of metagenomics market. During
the initial stages of the pandemic, research activities slowed down
significantly due to lockdowns and supply chain disruptions. This adversely
affected the demand for metagenomics products and services. However, with the
pandemic unfolding, researchers turned their focus towards understanding how
the novel coronavirus is evolving and spreading in the environment using
metagenomics techniques. Several studies analyzed wastewater samples and other
environmental specimens to detect the presence of SARS-CoV-2. This has helped
public health agencies take preventive measures and curb community
transmission. Post pandemic, the focus on preventing future outbreaks through
environment surveillance is expected to boost the metagenomics market. The
pandemic also highlighted the need for rapid pathogen identification which can
be facilitated through metagenomics. This is likely to drive further
investments in the development of accurate and high-throughput metagenomics
platforms.
Geographical Regions with High Concentration in Metagenomics Market
North America accounts for the largest share of the global metagenomics market
in terms of value. This is attributed to presence of major market players and
research institutes in the US and Canada. Significant investments by government
and private entities have propelled technological advancements and
commercialization of metagenomics products in the region.
Fastest Growing Region in Metagenomics Market
Asia Pacific region exhibits most promising growth prospects for metagenomics
market. This is due to rapidly developing economies, growing biotechnology
industry, and expanding healthcare infrastructure across major Asian countries.
Governments in emerging nations like China and India are introducing favorable
policies and funding initiatives to encourage life science research including
metagenomics.
Get More
Insights on- Metagenomics
Market
About
Author:
Alice Mutum is a seasoned senior content editor at Coherent
Market Insights, leveraging extensive expertise gained from her previous role
as a content writer. With seven years in content development, Alice masterfully
employs SEO best practices and cutting-edge digital marketing strategies to
craft high-ranking, impactful content. As an editor, she meticulously ensures
flawless grammar and punctuation, precise data accuracy, and perfect alignment
with audience needs in every research report. Alice’s dedication to excellence
and her strategic approach to content make her an invaluable asset in the world
of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137
)
